Evidence map›Paper›PMID 40097736›Full record

ArticleNature chemical biology2025

De novo biosynthesis of plant lignans by synthetic yeast consortia.

Ruibing Chen, Xianghui Chen, Yu Chen, Jindong Yang, Wansheng Chen, Yongjin J Zhou, Lei Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Engineering an asymmetric cross-feeding consortium inSynthetic and systems biotechnology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Microbial production of xanthohumol driven by synthetic biology approaches.World journal of microbiology & biotechnology · 2026
    Review
  6. Biomanufacturing of Natural Bioactive Compounds.Molecules (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruibing Chen *Department of Pharmaceutical Botany, School of Pharmacy, Naval Medical University, Shanghai, China.ORCID http://orcid.org/0000-0002-7933-3670
Xianghui Chen *Department of Pharmaceutical Botany, School of Pharmacy, Naval Medical University, Shanghai, China.
Yu ChenKey Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.ORCID http://orcid.org/0000-0003-3326-9068
Jindong YangDepartment of Pharmaceutical Botany, School of Pharmacy, Naval Medical University, Shanghai, China.
Wansheng ChenDepartment of Pharmacy, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China. chenwansheng@shutcm.edu.cn.ORCID http://orcid.org/0000-0002-0025-1315
Yongjin J ZhouDivision of Biotechnology, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China. zhouyongjin@dicp.ac.cn.ORCID http://orcid.org/0000-0002-2369-3079
Lei ZhangDepartment of Pharmaceutical Botany, School of Pharmacy, Naval Medical University, Shanghai, China. leizhang100@163.com.ORCID http://orcid.org/0000-0002-2494-5696

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32170274
6 · The paper itself

Abstract

Reconstructing the biosynthesis of complex natural products such as lignans in yeast is challenging and can result in metabolic promiscuity, affecting the biosynthetic efficiency. Here we divide the lignan biosynthetic pathway across a synthetic yeast consortium with obligated mutualism and use ferulic acid as a metabolic bridge. This cooperative system successfully overcomes the metabolic promiscuity and synthesizes the common precursor, coniferyl alcohol. Furthermore, combined with systematic engineering strategies, we achieve the de novo synthesis of key lignan skeletons, pinoresinol and lariciresinol, and verify the scalability of the consortium by synthesizing complex lignans, including antiviral lariciresinol diglucoside. These results provide a starting engineering platform for the heterologous synthesis of lignans. In particular, the study illustrates that the yeast consortium with obligate mutualism is a promising strategy that mimics the metabolic division of labor among multiple plant cells, thereby improving the biosynthesis of long pathways and complex natural products.

Indexed as

LignansSaccharomyces cerevisiaeBiosynthetic PathwaysCoumaric AcidsFuransMetabolic EngineeringPhenolsconiferyl alcoholCoumaric Acidsferulic acidFuranslariciresinolLignansPhenolspinoresinol

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.